Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_857763bdcd149edc5708fb87d0f0dbbd http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1721d75f5bf603447ec5a26b5c1c0be0 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3bc2c62f0a7c627731db452f3eb4f2aa http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c8909b5f9931c800adcc6688cca00d8d |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y304-21022 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-644 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2854 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-4846 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-70564 |
classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-64 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-705 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-48 |
filingDate |
2003-10-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2012-03-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_41b01c67c6b5ced6241fe5a56b4d68fb http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3f96aeb12648699030b573f6a621632b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_641ddea481b15c786e0d563f3fc7fd5e |
publicationDate |
2012-03-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-8128963-B2 |
titleOfInvention |
Methods for treating ischemic disorders using carbon monoxide |
abstract |
The present invention provides for a method for treating an ischemic disorder in a subject which comprises administering to the subject a pharmaceutically acceptable form of a selectin antagonist in a sufficient amount over a sufficient time period to prevent white blood cell accumulation so as to treat the ischemic disorder in the subject. The invention further provides a method for treating an ischemic disorder in a subject which comprises administering to the subject carbon monoxide gas in a sufficient amount over a sufficient period of time thereby treating the ischemic disorder in the subject. The invention further provides a method for treating an ischemic disorder in a subject which comprises administering to the subject a pharmaceutically acceptable form of inactivated Factor IX in a sufficient amount over a sufficient period of time to inhibit coagulation so as to treat the ischemic disorder in the subject. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8778413-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011280966-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8293231-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010303800-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10342821-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11389471-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2014287066-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9789133-B2 |
priorityDate |
1996-09-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |